Why Partner?
Following an initial explosion of excitement across the allogeneic space, challenges around safety and long-term persistence and durability has highlighted the need for the industry to determine key contributing factors affecting the product performance – one of which is the starting quality of the cell source material being utilized.
As the allogeneic space continues to ramp up clinical development, drug developers are realizing the need to plan ahead in donor management and develop robust processes to support scale up.
From our research, leading experts in the field have mentioned they need help from service providers and require meaningful partnerships to aid with characterization testing, donor recruitment, retention, management and more!
The 2nd Donor Selection and Cell Source Summit provides the unique opportunity to position your trusted expertise to those at the forefront of building out their donor requirements for allogeneic cell therapy pipelines.
Top Reasons to Partner:
Position Yourself as an Industry Thought Leader: Present to key market decision makers and showcase your expertise through presentations, panel discussions, or roundtables.
Raise Brand Awareness:
Expand your reach to new clients and businesses with unique branding opportunities before and after the conference.
Meet and Network with Industry Pioneers:
Connect with drug developers focused on allogeneic cell therapies and generate new leads for 2024 and beyond through meetings and networking.
Benefit from Market Intelligence:
Learn about the biopharma investments in large-scale off-the-shelf therapies for 2024 to align your solutions accordingly.
Who Will You Meet?
2024 Partners:
